Latest Equity Raise News

Caravel Minerals has locked in a $15 million loan facility to fund the critical Definitive Feasibility Study for its flagship Caravel Copper Project, advancing the path to development without diluting shareholder equity.

Genetic Technologies Limited has signed binding term sheets to acquire Ellerfield Wealth and Walker Capital, marking a strategic shift into wealth management backed by a $7.8 million valuation and pending ASX approvals.

FireFly Metals has secured C$25.8 million through a Canadian bought deal and an A$46 million Australian equity raise to fund expansion and exploration at its Green Bay Copper-Gold Project in Newfoundland.

BetMakers Technology Group launches a $13.5 million equity raise to fund the acquisition of Las Vegas Dissemination Company and strengthen its financial position amid improving operational metrics.

Empire Energy Group has launched a $28 million equity raise to finance critical development activities in the Beetaloo Basin, targeting first gas sales from its Carpentaria Pilot Project in 2025. The capital raise, combined with a $65 million financing package, underpins the company’s ambition to commercialize one of Australia’s largest low-CO2 shale gas resources.

Challenger Gold has completed a Pre-Feasibility Study for toll milling at its Hualilan Gold Project, revealing strong economics, low capital requirements, and a swift payback period. The study underscores the project's potential to generate significant cash flow over three years through a toll milling arrangement with Austral Gold.

Babylon Pump & Power Limited (ASX – BPP) announces transformational acquisitions of Blue Hire and Matrix Hydro Services, significantly expanding its equipment rental and water management capabilities. The company is funding this growth through a $3.5 million entitlement offer and a $21.2 million debt facility, targeting a doubling of EBITDA by FY26.

Cardiex Digital Vascular Biomarkers announces a A$6.5 million equity raise to fund inventory, marketing, product development, and debt repayment, aiming to solidify its position in the expanding cardiovascular health market.

Cann Group Limited has reported a strong operational update, exceeding its medicinal cannabis production targets and significantly reducing costs, while expanding sales channels and securing fresh capital to bolster its balance sheet.

Pacific Edge Limited has launched a NZ$20 million capital raise to bolster its cash reserves amid the loss of Medicare coverage for its bladder cancer diagnostic tests, aiming to accelerate US market adoption and support new product development.

Pacific Edge Limited reported a resilient FY25 performance despite losing Medicare coverage for its Cxbladder tests in the US, announcing a $20 million equity raise to support commercialization and growth.

Agrimin Limited has successfully raised $2.5 million through an oversubscribed equity placement to fund the strategic review of its Mackay Potash Project and explore new mineral opportunities.